Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset the ATLANTIS study: A randomized controlled trial

Wayne Clark, Stanley Wissman, Gregory W. Albers, Jack H. Jhamandas, Kenneth P. Madden, Scott Hamilton

955 Scopus citations
Original languageEnglish (US)
Pages (from-to)2019-2026
Number of pages8
JournalJournal of the American Medical Association
Issue number21
Publication statusPublished - Dec 1 1999


ASJC Scopus subject areas

  • Medicine(all)

Cite this